Access to high-priced medicines: Inequalities in the organization and the results among Brazilian states

5Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This case study aimed to characterize the Specialized Component of Pharmaceutical Services (CEAF) organization in four Brazilian states from diverse regions of the country. Data were collected with representatives of CEAF management from states in different regions, who answered a 21-question questionnaire on scope, organization, financing, hurdles, and facilitators. This information was complemented with data from national health surveys, DataSUS, the applied resources, and socioeconomic indicators. Differences were observed between states on issues such as the proportion of users and the decentralization of services. These characteristics seem to be related to the level of development concerning the socioeconomic indicators used. Advances in access to medicines were highlighted, despite the difficulties complying with the CEAF’s objectives, such as insufficient resources, the qualification of human resources, and the provision of necessary visits and exams. The results point to advances, different forms of organization and highlight the need for more in-depth studies on the clinical and economic outcomes achieved as a strategy to outline solutions to achieve the comprehensive and equal care for users.

Cite

CITATION STYLE

APA

Rover, M. R. M., Faraco, E. B., Vargas-Peláez, C. M., Colussi, C. F., Storpirtis, S., Farias, M. R., & Leite, S. N. (2021). Access to high-priced medicines: Inequalities in the organization and the results among Brazilian states. Ciencia e Saude Coletiva, 26(11), 5499–5508. https://doi.org/10.1590/1413-812320212611.27402020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free